Donate Now Become a member

Cart (0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

DIA Global Center

Sep 11, 2017 8:15 AM - Sep 12, 2017 3:30 PM

21 Dupont Circle NW, Suite 300, Washington, DC 20036

Navigating Chemistry, Manufacturing, and Controls Through the Drug Development Process

Back to Agenda

Sessions 25 and 26

Session Chair(s)

Albert S. Yehaskel, MBA

Albert S. Yehaskel, MBA

President and CEO

Refuah Global Pharmaceutical Development, Inc., United States

Session 25: Beyond Approval – Post Approval Changes

This section will drill down into the realm of post approval changes such as PAS's, CBE's, and ARs
SUPAC documents will be discussed which are integral in the post approval world

Session 26: Changes Reportable in an Annual Reports

Components and Composition
Manufacturing Sites and Process
Specifications
Container/Closure System

Have an account?